Xenex Disinfection Services announces it has signed a national contract with HealthTrust, a leading group purchasing and total cost management organization that serves 1,350 acute-care facilities nationwide. The contract, which covers Xenex Germ-Zapping Robots™, became effective June 1, 2015.
Xenex’s pulsed xenon Full Spectrum™ ultraviolet (UV) room disinfection solution reduces the bacterial load in hospitals that is often associated with an increased risk for healthcare-associated infections (HAIs). The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores in a five-minute disinfection cycle. Without contact or chemicals, the robot eliminates harmful microorganisms safely and effectively. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in nearly 300 hospitals, healthcare facilities of the U.S. Department of Veterans Affairs and Department of Defense, skilled nursing facilities, ambulatory surgery centers and long-term acute care facilities in the U.S. and Europe.
“We’re able to help hospitals provide a safer environment by eliminating the dangerous superbugs that pose a threat to patients and hospital workers,” says Morris Miller, CEO of Xenex.
“Xenex is dedicated to environmental responsibility and the safety of hospital employees and patients,” says Mark Stibich, PhD, Xenex co-founder and chief scientific officer. “Xenex germ-zapping robots use full spectrum pulsed xenon flash lamps instead of mercury bulbs to create germicidal UV light. Using the robots, hospital environmental services staff are able to disinfect 30 to 60 rooms per day, including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas, without disrupting hospital operations.”
Xenex's patented Full Spectrum™ pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. The Xenex mission is to save lives and reduce suffering by eliminating the deadly microorganisms that cause hospital-acquired infections. The company is backed by well-known investors that include Brandon Point/Malin Corporation, Battery Ventures, Targeted Technology Fund II and RK Ventures.
Source: Xenex Disinfection Services
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.